secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pyxis Oncology, Inc. (PYXS)
CIK:        0001782223
Form:       8-K
Filed at:   2025-07-03T23:59:59+00:00
Accession:  0000950170-25-093456
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pyxis Oncology CFO/COO Pamela Connealy retires; Jitendra Wadhane appointed PFO
------------------------------------------------------------------------------

- Pamela Connealy, CFO and COO, retired from Pyxis Oncology effective July 1, 2025; not due to any disagreement.
- Jitendra Wadhane, current SVP Finance and CAO, appointed Principal Financial Officer effective same date.
- Wadhane continues as Principal Accounting Officer; no additional compensation for PFO role.
- Connealy eligible for severance benefits per her Amended and Restated Employment Agreement (Nov 2022).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782223/000095017025093456/0000950170-25-093456-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782223/000095017025093456/pyxs-20250701.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-093456

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer